- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01681329
Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder (CBT+IMT-GAD)
Improving Outcomes for Adults With Generalized Anxiety Disorder: Combining Cognitive-Behavioral Treatment and Interpretation Modification Training
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Generalized Anxiety Disorder (GAD) is characterized by excessive and uncontrollable worry and anxiety. In Canada, the point prevalence of GAD is 3 to 4%, and the personal and social costs of GAD are well documented. Over the past decade, new cognitive-behavioural treatments have been developed for GAD. Our group has also developed a cognitive-behavioural treatment (CBT) protocol for GAD, which focuses on intolerance of uncertainty. There are now four published randomized clinical trials of the treatment, with results suggesting that it is more efficacious than wait-list control, supportive therapy, and applied relaxation. Although these results are encouraging, 30 to 40% of affected individuals do not attain diagnostic remission and 45 to 50% do not achieve high endstate functioning at post-treatment.
In an effort to augment the efficacy of the treatment protocol for GAD, we have recently examined a broad range of demographic and clinical variables that might predict a limited response to treatment. The results of our analyses suggest that a particular type of cognitive bias plays a key role in determining treatment response. Specifically, patients with a particularly negative interpretation style (i.e., the tendency to negatively interpret ambiguous information) have a greater probability of not attaining remission following CBT (they also show less improvement on other indicators of treatment outcome). In addition, change in interpretation style appears to mediate change in GAD symptoms over the course of CBT. Thus, the data suggest that treatment efficacy could be increased by adding training strategies that specifically address negatively biased interpretations of ambiguous information. Recently, a number of experimental investigations have shown that the tendency to negatively interpret ambiguous information can be decreased using computerized interpretation modification training. In fact, the data show that such changes can be maintained over time, can generalize to new situations, and can lead to corresponding changes in GAD symptoms and anxiety proneness. Thus, it appears that computerized interpretation modification training has the potential to increase the efficacy of current CBT protocols by directly targeting and decreasing the tendency to negatively interpret ambiguous information.
The proposed randomized clinical trial addresses the following question: Can computerized interpretation modification training augment the efficacy of CBT for GAD? A total of 138 individuals with a primary diagnosis of GAD will be randomly allocated to one of two conditions: a) CBT plus interpretation modification training (CBT+IMT) or b) CBT plus non-active training (CBT+NA). CBT will consist of 14 weekly 50-minute sessions targeting intolerance of uncertainty via procedures such as problem-solving training and imaginal exposure. Participants randomized to the experimental condition will receive 10 minutes of computerized interpretation modification training prior to each CBT session. In interpretation modification training, respondents learn to endorse benign combinations and reject negative combinations of sentences and words, thus promoting new associative learning. Participants in the control condition will receive 10 minutes of non-active training, in which each sentence is paired with a word that is unrelated to the sentence or a word that is related to a non-threatening (and typically peripheral) aspect of the sentence. Measures of GAD symptoms, psychopathology, cognitive vulnerability, and interpretation style will be administered at pre-, mid-, and post-treatment, as well as at 6- and 12-month follow-ups. The proposed study will provide information about the efficacy, clinical usefulness, and mechanisms of interpretation modification training in combination with CBT. Given previous findings on the key role of negative interpretation style in anxiety, the proposed study has the potential to increase our understanding and ability to treat individuals with GAD.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H3M 3A9
- Hôpital du Sacré-Coeur de Montréal, Clinique des troubles anxieux
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Principal diagnosis of GAD
- Willingness to keep medication status stable while participating in the study
- Willingness to undergo randomization
Exclusion Criteria:
- Change in medication type or dose in 12 weeks before study entry
- Use of herbal products known to have CNS effects in the 2 weeks before study entry
- Evidence of suicidal intent
- Evidence of current substance abuse
- Evidence of current or past schizophrenia, bipolar disorder or organic mental disorder
- Current participation in other trials
- Concurrent psychotherapy during treatment phase of trial
- Evidence of anxiety symptoms due to a general medical condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive-behavioral therapy with interpretation training
14 sessions of cognitive-behavioral therapy combined with computerized interpretation modification training
|
Cognitive-behavioral therapy addressing intolerance of uncertainty, positive beliefs about worry, negative problem orientation, and cognitive avoidance
Other Names:
Computerized interpretation training using Word-Sentence Association Paradigm
Other Names:
|
|
Active Comparator: Cognitive-behavioral therapy with non-active training
14 sessions of cognitive-behavioral therapy combined with computerized non-active training
|
Cognitive-behavioral therapy addressing intolerance of uncertainty, positive beliefs about worry, negative problem orientation, and cognitive avoidance
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in severity of GAD symptoms assessed by structured interview
Time Frame: Post-treatment (14 weeks)
|
Clinician's Severity Rating (CSR) scale of Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV)
|
Post-treatment (14 weeks)
|
|
Change from baseline in severity of GAD symptoms
Time Frame: Post-treatment (14 weeks)
|
Worry and Anxiety Questionnaire (WAQ)
|
Post-treatment (14 weeks)
|
|
Change from baseline in severity of worry
Time Frame: Post-treatment (14 weeks)
|
Penn State Worry Questionnaire (PSWQ)
|
Post-treatment (14 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in somatic anxiety
Time Frame: Post-treatment (14 weeks)
|
Beck Anxiety Inventory (BAI)
|
Post-treatment (14 weeks)
|
|
Change from baseline in depressive symptoms
Time Frame: Post-treatment (14 weeks)
|
Beck Depression Inventory, 2nd edition (BDI-II)
|
Post-treatment (14 weeks)
|
|
Change from baseline in hostile attitudes
Time Frame: Post-treatment (14 weeks)
|
Aggression Questionnaire, Hostility subscale (AQ-Host)
|
Post-treatment (14 weeks)
|
|
Change from baseline in intolerance of uncertainty
Time Frame: Post-treatment (14 weeks)
|
Intolerance of Uncertainty Scale (IUS)
|
Post-treatment (14 weeks)
|
|
Change from baseline in beliefs about worry
Time Frame: Post-treatment (14 weeks)
|
Why Worry, 2nd edition (WW-II)
|
Post-treatment (14 weeks)
|
|
Change from baseline in problem orientation
Time Frame: Post-treatment (14 weeks)
|
Negative Problem Orientation Questionnaire (NPOQ)
|
Post-treatment (14 weeks)
|
|
Change from baseline in cognitive avoidance
Time Frame: Post-treatment (14 weeks)
|
Cognitive Avoidance Questionnaire (CAQ)
|
Post-treatment (14 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in interpretation of scrambled sentences
Time Frame: Post-treatment (14 weeks)
|
Scrambled Sentence Task for GAD (SST-GAD)
|
Post-treatment (14 weeks)
|
|
Change from baseline in interpretation of ambiguous scenarios
Time Frame: Post-treatment (14 weeks)
|
Ambiguous/Unambiguous Situations Diary, Extended version (AUSD-Ext)
|
Post-treatment (14 weeks)
|
|
Change from baseline in interpretation of ambiguous pictures
Time Frame: Post-treatment (14 weeks)
|
Affective Picture Rating Task (APRT)
|
Post-treatment (14 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michel J. Dugas, Ph.D., Concordia University, Montreal
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOP-82771-12-04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)RecruitingGeneralized Anxiety Disorder (GAD)United States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Wayne State UniversityNational Institute of Mental Health (NIMH)RecruitingAnxiety Disorders | Generalized Anxiety Disorder (GAD)United States
-
AbbVieRecruitingGeneralized Anxiety Disorder (GAD)United States, Puerto Rico
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
National Health Research Institutes, TaiwanNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
Psicofarma, S.A. De C.V.Recruiting
-
Bout Me HealingCompletedSubstance Use Disorder (SUD) | Anxiety Disorder GeneralizedUnited States
-
Definium Therapeutics US, Inc.CompletedAnxiety GeneralizedUnited States
Clinical Trials on Cognitive-behavioral therapy
-
Aleksandra StojanovicRecruitingAnxiety Disorders | Depression - Major Depressive DisorderSerbia
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States
-
Duke UniversityCompleted